Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Isotretinoin was not effective in treating facial lichen planopilaris.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.

The higher dose supplement was more effective in treating female hair loss.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.